On January 28, 2025, President Trump signed Executive Order 14187, titled “Protecting Children from Chemical and Surgical Mutilation,” aiming to restrict gender-affirming medical interventions for minors under 19.
Key Implications for Health Systems
Funding Restrictions: The order directs federal agencies to withhold funding from medical institutions providing gender-affirming care to minors, affecting hospitals and clinics reliant on federal grants. (Winston & Strawn LLP)
Policy Revisions: Institutions must revise policies to comply with the order, potentially halting services like hormone therapies and surgeries for transgender youth. (Winston & Strawn LLP)
Legal Challenges: Several states and organizations have filed lawsuits against the order, resulting in temporary injunctions that prevent enforcement while legal proceedings continue. (NBC News)
What’s Next for Health Systems?
Health systems should:
- Monitor Legal Developments: Stay informed about ongoing litigation and adjust policies accordingly.
- Assess Funding Sources: Evaluate reliance on federal funding and explore alternative sources to mitigate potential financial impacts.
- Support Affected Patients: Develop strategies to provide care and support for transgender youth within the evolving legal framework.
This executive order presents significant challenges for health systems, necessitating proactive measures to navigate the changing regulatory environment while ensuring patient care and institutional compliance.